| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 841,7 k € | +19.8% | 702,3 k € | +25.7% | 558,8 k € | +240.3% | 164,2 k € | -90.0% | 1,6 M € | +65.2% | 990,1 k € | -41.0% | 1,7 M € | -11.6% | 1,9 M € | +3.0% | 1,8 M € | +32.9% | 1,4 M € | +0.6% | 1,4 M € | +12.6% | 1,2 M € | -10.0% | 1,4 M € | +13.4% | 1,2 M € | +0.5% | 1,2 M € | +60.2% | 744,1 k € | +0.3% | 741,7 k € | +178.3% | 266,5 k € | -42.8% | 465,8 k € | |
| EBITDA | 612,0 k € | +20.4% | 508,4 k € | +39.7% | 363,9 k € | +1966.3% | 17,6 k € | -98.6% | 1,3 M € | +84.2% | 705,9 k € | -48.4% | 1,4 M € | -10.9% | 1,5 M € | +5.7% | 1,5 M € | +32.7% | 1,1 M € | -0.4% | 1,1 M € | +13.9% | 964,8 k € | -12.4% | 1,1 M € | +60.3% | 687,0 k € | -12.7% | 787,0 k € | +49.8% | 525,4 k € | -9.0% | 577,6 k € | +356.3% | 126,6 k € | -68.2% | 398,5 k € | |
| Operating profit | 555,5 k € | +28.5% | 432,3 k € | +50.9% | 286,5 k € | +532.6% | -66,2 k € | -105.5% | 1,2 M € | +103.3% | 592,4 k € | -52.8% | 1,3 M € | -11.4% | 1,4 M € | +7.2% | 1,3 M € | +37.3% | 961,8 k € | -5.1% | 1,0 M € | +15.5% | 877,6 k € | -13.9% | 1,0 M € | +64.0% | 621,4 k € | -14.3% | 725,3 k € | +52.0% | 477,2 k € | -10.1% | 530,9 k € | +572.6% | 78,9 k € | -77.6% | 352,8 k € | |
| Profit/loss | 381,4 k € | +29.2% | 295,2 k € | +36.6% | 216,1 k € | +370.6% | -79,8 k € | -109.9% | 806,8 k € | +126.3% | 356,5 k € | -60.4% | 899,6 k € | +8.7% | 827,8 k € | +25.9% | 657,4 k € | +31.4% | 500,5 k € | -18.5% | 614,0 k € | +4.0% | 590,6 k € | -27.0% | 809,2 k € | +94.4% | 416,2 k € | -13.6% | 481,8 k € | +56.3% | 308,2 k € | -9.1% | 339,2 k € | +542.2% | 52,8 k € | -78.3% | 243,3 k € | |
| Equity | 4,2 M € | +1.6% | 4,1 M € | +7.7% | 3,8 M € | +6.0% | 3,6 M € | -13.9% | 4,2 M € | -14.9% | 4,9 M € | +7.8% | 4,5 M € | +3.1% | 4,4 M € | +23.1% | 3,6 M € | +22.5% | 2,9 M € | +20.6% | 2,4 M € | +131.6% | 1,0 M € | -38.6% | 1,7 M € | +90.1% | 898,3 k € | -11.2% | 1,0 M € | +91.0% | 529,7 k € | +62.2% | 326,5 k € | +15.6% | 282,3 k € | +23.0% | 229,5 k € | |
| Total assets | 4,4 M € | +0.3% | 4,4 M € | +8.3% | 4,1 M € | -9.1% | 4,5 M € | -26.9% | 6,1 M € | +13.8% | 5,4 M € | +7.5% | 5,0 M € | +1.7% | 4,9 M € | +15.6% | 4,2 M € | +21.1% | 3,5 M € | +14.7% | 3,1 M € | +7.0% | 2,9 M € | +13.4% | 2,5 M € | +17.5% | 2,1 M € | +31.9% | 1,6 M € | +55.9% | 1,0 M € | -0.3% | 1,0 M € | +25.2% | 835,1 k € | +27.9% | 653,1 k € | |
| Cash | 1,5 M € | +6.0% | 1,4 M € | +11.0% | 1,3 M € | -36.1% | 2,0 M € | +30.2% | 1,6 M € | +11.8% | 1,4 M € | +84.8% | 756,7 k € | -45.5% | 1,4 M € | -3.4% | 1,4 M € | -10.3% | 1,6 M € | -11.0% | 1,8 M € | +48.9% | 1,2 M € | +1.8% | 1,2 M € | -3.4% | 1,2 M € | +14.3% | 1,1 M € | +141.8% | 444,6 k € | +54.2% | 288,3 k € | +152.2% | 114,3 k € | -24.9% | 152,2 k € | |
| Debts | 242,6 k € | -17.3% | 293,3 k € | +16.6% | 251,5 k € | -71.2% | 873,4 k € | -54.9% | 1,9 M € | +318.0% | 463,0 k € | +3.8% | 445,9 k € | -10.0% | 495,4 k € | -23.3% | 646,2 k € | +14.8% | 563,1 k € | -5.6% | 596,4 k € | -66.7% | 1,8 M € | +126.1% | 792,7 k € | +28.5% | 617,0 k € | +113.5% | 289,0 k € | -34.0% | 437,6 k € | -39.1% | 718,4 k € | +30.2% | 551,6 k € | +30.2% | 423,6 k € | |
| Staff | 2,3 | 2,4 | 2,5 | 3 | 3,6 | 3,9 | 4,3 | 4,7 | 6,1 | 4,8 | 4,9 | 3,8 | 4,8 | 3,7 | 3,3 | 3 | 3,7 | 3,4 | 1,8 | |||||||||||||||||||
Private limited company · Harelbeke · incorporated on 21/11/2005 · 2,3 ETP
Private limited company profitable and well capitalised. Cash position rising (+6.0%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
ORTHOTECHNICS is a Private limited company incorporated in 2005. Its main activity is: Manufacture of medical and dental instruments and supplies. Its registered office is in Harelbeke. It employs on average 2,3 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette